MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ)

$3.8303 -0.1747 (-4.362%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 69

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ) News Sources

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

01-05-2026

yahoo.com

external link

Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences

04-05-2026

yahoo.com

external link

Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317

12-05-2026

yahoo.com

external link

Eckert & Ziegler SE (XTER:EUZ) Q1 2026 Earnings Call Highlights: Strong Medical Division ...

14-05-2026

yahoo.com

external link

Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation Summit

26-05-2026

yahoo.com

external link

Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1

30-05-2026

yahoo.com

external link

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

02-07-2026

yahoo.com

external link

Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics

06-07-2026

yahoo.com

external link

Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference

15-07-2026

yahoo.com

external link

Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma

16-07-2026

yahoo.com

external link

MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ) Sentiment Trend

0 25 50 75 100 65 63 61 53 77 70 71 77 80 75 01-05-2026 04-05-2026 12-05-2026 14-05-2026 26-05-2026 30-05-2026 02-07-2026 06-07-2026 15-07-2026 16-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ) FAQs

toggle

What is the current price of MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ)?

The current price of MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ) is $3.8303.


toggle

MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ) absolute price change since previous trading day?

The absolute price change of MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ) since the previous trading day is $-0.1747.


toggle

MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ) percentage price change since previous trading day?

The percentage price change of MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ) since the previous trading day is -4.362%.


toggle

What is the most recent average sentiment score for MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ)?

The most recent average sentiment score for MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ) is 69 out of 100.


toggle

What is the most recent average sentiment for MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ)?

The most recent sentiment for MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ) is .


SEC-8K** Filing Available For MOLECULAR PARTNERS AG -ADR (MOLN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

NA (Nano Labs Ltd ADR)
PHAR (Pharming Group N.V. ADR)
CLGN (Collplant Biotechnologies Ltd ADR)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.